Enzychem Lifesciences Corporation (KOSDAQ:183490)
South Korea
· Delayed Price · Currency is KRW 1,074.00
-22.00 (-2.01%)
At close: Dec 5, 2025
Enzychem Lifesciences Revenue
Enzychem Lifesciences had revenue of 16.47B KRW in the quarter ending September 30, 2025, a decrease of -3.18%. This brings the company's revenue in the last twelve months to 72.17B, down -12.06% year-over-year. In the year 2024, Enzychem Lifesciences had annual revenue of 77.38B with 1.76% growth.
Revenue (ttm)
72.17B
Revenue Growth
-12.06%
P/S Ratio
1.16
Revenue / Employee
555.16M
Employees
130
Market Cap
83.38B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |